|[January 14, 2014]
RBCC Opens Talks with Top Innovators at Major Biotech Conference
MIRAMAR BEACH, Fla. --(Business Wire)--
The executive leadership of Rainbow Coral Corp. (OTCBB:RBCC), a
biotechnology company, is spending its week meeting with potential
partners and innovators in San Francisco at one of the largest and most
important biotechnology conferences in the world.
Running through Wednesday, the sixth annual Biotech Showcase is an
established innovation forum for life science investors that draws
industry professionals from around the globe. Executive-level delegates
representing top public and private investment firms come to network and
partner with emerging biotechnology and life science companies on the
RBCC execs will spend the conference seeking out and investigating
technology innovators on the rise who could potentially help the company
achieve its ambitious goals for 2014. The company's primary focus is on
drug delivery with an emphasis on personal and regenerative medicine.
"The top movers and shakers in biotechnology are all in San Francisco
this week," said RBCC CEO Kimberly Palmer. "There's no better place in
the country for RBCC to make new contacts that could turn into lucrative
new development partnerships than at the Biotech Showcase. It's like an
exciting early glimpse at the industry's future."
By acquiring or partnering with up-and-coming biotech innovators, RBCC
plans to be well-positioned to capitalize on the big growth in store for
the industry. The company invests in new technology developed to compete
in the biotechnology sector alongside Amgen (NASDAQ: AMGN), Dendreon
Corporation (NASDAQ: DNDN), Smith & Nephew (NYSE: SNN) and
Pharmaceutical Product Development (NASDAQ: PPDI).
For more information on RBCC's other biotech initiatives, please visit www.rainbowbiosciences.com.
About Rainbow Biosciences
Rainbow Biosciences, LLC, is a wholly owned subsidiary of Rainbow Coral
Corp. (OTCBB:RBCC). The Company continually seeks out new partnerships
with biotechnology developers to deliver profitable new medical
technologies and innovations. For more information on our
growth-oriented business initiatives, please visit www.RainbowBioSciences.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act
of 1995: This news release contains forward-looking information within
the meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
including statements that include the words "believes," "expects,"
"anticipate" or similar expressions. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of the Company
to differ materially from those expressed or implied by such
forward-looking statements. In addition, description of anyone's past
success, either financial or strategic, is no guarantee of future
success. This news release speaks as of the date first set forth above
and the Company assumes no responsibility to update the information
included herein for events occurring after the date hereof.
[ Back To TMCnet.com's Homepage ]